about
Role of chemotherapy in nasopharyngeal carcinomaSubcutaneous Tissue Expander Placement with Synthetic Titanium-Coated Mesh in Breast Reconstruction: Long-term Results.Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.Combined modality therapy for thoracic and head and neck cancers: a review of updated literature based on a consensus meeting.Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience.Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy.Gamma Knife Radiosurgery in the management of single and multiple brain metastases.Two-stage implant based breast reconstruction: should we always exchange the tissue expander for an implant right away?Late relapse in testicular germ cell tumors.Management of Stage II testicular seminoma over a period of 40 years.Radiosensitivity in the breast cancer management scenario: another step forward?Multiple cutaneous angiosarcomas after breast conserving surgery and bilateral adjuvant radiotherapy: an unusual case and review of the literature.A PPAR-gamma agonist protects from radiation-induced intestinal toxicity.Oral ibandronate in metastatic bone breast cancer: the Florence University experience and a review of the literature.Postmastectomy radiotherapy in breast cancer adjuvant treatment.Postoperative radiotherapy in stage I/II endometrial cancer: retrospective analysis of 883 patients treated at the University of Florence.Management of inflammatory breast cancer: focus on radiotherapy with an evidence-based approach.Simultaneous integrated boost-intensity-modulated radiotherapy in head and neck cancer.Phyllodes tumours of the breast diagnosed as B3 category on image-guided 14-gauge core biopsy: analysis of 51 cases from a single institution and review of the literature.Hypofractionation in prostate cancer: radiobiological basis and clinical appliance.The use of psychological supportive care services and psychotropic drugs in patients with early-stage breast cancer: a comparison between two institutions on two continents.Radiotherapy in the age of cancer immunology: Current concepts and future developments.Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial.Overview on cardiac, pulmonary and cutaneous toxicity in patients treated with adjuvant radiotherapy for breast cancer.A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model.Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: Long-term experience from two large-institutional series.Complete response in metastatic renal cell carcinoma after radiotherapy and everolimus: a clinical case and review of the literature.Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience.Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin.Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study.Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature.SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab.Current trends and outcomes of breast reconstruction following nipple-sparing mastectomy: results from a national multicentric registry with 1006 cases over a 6-year period.Core needle biopsy for the assessment of unilateral male breast lesions.Treatment of invasive male breast cancer: a 40-year single-institution experience.Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer.Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy.Microinvasive breast cancer: pathological parameters, cancer subtypes distribution, and correlation with axillary lymph nodes invasion. Results of a large single-institution series.Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer.Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial.
P50
Q27022454-59ED3E19-BB2F-4707-84CF-BD4B368E660AQ27317244-0116E1AF-A228-4DC2-B6AE-903BE59A3371Q30240601-1D006E17-4640-4681-AB40-3529F0B2D90DQ30248531-59171059-1A8D-4A1E-A695-3FC3DEBED352Q33379858-D3F038DE-A675-4715-8205-2A45A9135821Q33876719-EB8627E1-EE2F-4B5E-A367-24D1C9AD9FC1Q35885609-B03A690A-EC4E-4DFF-AB88-5C0493EE2F5FQ36945971-5AED70E9-B935-47F2-8DD7-899B0B5DCD2EQ37014502-BF081347-E22C-4380-858A-A77BCCAFCE71Q37291821-ED2996BD-F2FB-44AE-B288-46EB6ADEAC7CQ37411215-8CC58AA0-6620-4E73-91EE-DDF5B2D53382Q37679593-49B4B090-4227-493C-B20B-3B977507495CQ37698546-59F558FF-D41D-476A-9A98-4DB73B246239Q37708869-90DC6C26-5C7F-4482-94C6-0A3D23DE1EBEQ37809952-3E01383C-945A-41D2-919F-786BD07D97B2Q37849272-ACD21683-AE93-495D-9011-108E63ACA404Q38008092-7AA3C224-9856-4F2A-BD85-0D6786E748F3Q38115170-5B86E299-D2DC-48B7-AB59-C98446899330Q38194676-A8A9AACB-2564-4B34-85D2-C4397D041C4BQ38226822-7470BF83-034E-4FE0-B768-4B090661B119Q38670989-0D3FB44F-F766-46E5-98E0-0C37A0F1F38EQ38742020-52C1052B-2D6F-4B1F-85C6-B83ACB2BEBE6Q38750321-24A89BA5-C277-45FF-909C-13A326F46DA7Q38792791-F05FE102-D18F-44DE-A364-5589B2992B23Q38801239-54650C7F-AA40-4695-9210-97B3ADAD5C1CQ38849891-EF0E5369-5BB9-412A-89D4-AE08451FC3BCQ38885327-E27B3B17-7014-407E-ADD7-5B55F5E47DD3Q38897959-886BF675-B996-4E40-9B85-1BC173E6BC20Q38913042-58C66CF6-F91F-4299-9DB6-5C14450B724CQ38958436-048FBCA3-08A7-448E-9388-4200B93EA6C8Q39212333-F148A8A0-28EB-4ED1-B714-2FD367F8C300Q39212340-D057089B-889F-4EA9-8CB7-B4BEB7DE8CEEQ39417378-023ECD60-9447-4619-B053-076366FE8D50Q39448068-1368F101-09B3-4939-9981-99EAD31F7816Q39572831-B2905B90-5960-40F4-B66C-B3548E275ED3Q39693600-203D42F1-7928-44E9-A090-1FCFFB17F068Q40505371-CD33C963-AAFB-46BB-AC4A-31A90D10CBADQ40931587-E9768436-32B4-4766-BFC1-DA23985D3099Q41385767-511111FB-ED15-475D-8871-8C06AA60AE9BQ41387966-98784E9C-034F-4972-B483-894ABB920E08
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Icro Meattini
@ast
Icro Meattini
@en
Icro Meattini
@es
Icro Meattini
@nl
Icro Meattini
@sl
type
label
Icro Meattini
@ast
Icro Meattini
@en
Icro Meattini
@es
Icro Meattini
@nl
Icro Meattini
@sl
prefLabel
Icro Meattini
@ast
Icro Meattini
@en
Icro Meattini
@es
Icro Meattini
@nl
Icro Meattini
@sl
P106
P1153
23027824500
P31
P496
0000-0002-1861-2895